Cancer Research & Cancer vaccines

The goal of the Cancer Research Program is to make significant improvements in the prevention, early detection, diagnosis and treatment of cancer. It will continue to translate basic research findings into clinical applications together with strategic partners, with the National Centre for Tumor Diseases (NCT) and the nationally active German Consortium for Translational Cancer Research (DKTK) playing key roles. Most of us know about vaccines given to healthy people to help prevent infections, such as measles and chicken pox. These vaccines use weakened or killed germs like viruses or bacteria to start an immune response in the body. Getting the immune system ready to defend against these germs helps keep people from getting infections. Most cancer vaccines work the same way, but they make the person’s immune system attack cancer cells.

    Related Conference of Cancer Research & Cancer vaccines

    September 01-02, 2017

    4th International Conference on Parasitology

    Prague, Czech Republic
    November 2-3, 2017

    9th World Congress and Expo on Immunology

    Atlanta, Georgia, USA
    November 02-03, 2017

    9th World Congress on Immunity, Inflammation and Immunotherapies

    Atlanta, Georgia, USA
    November 06-07, 2017

    2nd International Conference on Autoimmunity

    Frankfurt, Germany
    November 08-09, 2017

    3rd Antibodies and Bio Therapeutics Congress & B2B

    Las Vegas, Nevada, USA
    November 13-14, 2017

    5th International Conference on HIV/AIDS, STDs and STIs

    Las Vegas, Nevada, USA
    Dec 14-15, 2017

    World Immunology Congress

    Dubai, UAE

    9th European Immunology Conference

    June 14-16, 2018 Rome, Italy

    Cancer Research & Cancer vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in